News

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...
In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...
CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early ...
A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.
Clinical Trials Arena on MSN23h
How can pharma manage rising trial costs?
With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...
Dozens of NHS cancer patients will be offered a needle-free skin cancer vaccine to stop the disease returning in a major ...
A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...
and this information can be directly used to identify molecular biomarkers that will stratify patients.” Digital technology and ‘frictionless’ clinical trials The explosion of digital ...
Volume 17, Issue 3, on March 4, 2025, titled “Deciphering age-related transcriptomic changes in the mouse retinal pigment epithelium.” ...
A pioneering clinical trial backed by the EU and drugmaker Takeda will look for biomarkers that could be used to identify people at risk of developing Crohn's disease in the hope of intervening ...
Gastrointestinal (GI) cancers represent a significant global health burden with complex biological behaviors and ...
Researchers are developing new approaches to detect and treat cancer in smarter, safer and kinder ways.